JMI Hospital Requisite Manufacturing (DHA:JHRML) Research & Development: BDT0 Mil (TTM As of Mar. 2026)


DHA:JHRML JMI Hospital Requisite Manufacturing Ltd DHA:JHRML
67 GF Score
Price BDT52.60
GF Value BDT50.92
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is JMI Hospital Requisite Manufacturing Research & Development?

JMI Hospital Requisite Manufacturing DHA:JHRML +1.15% 67 Research & Development is BDT0 Mil as of Mar. 2026. GuruFocus rates DHA:JHRML with a GF Score™ of 67/100 and a GF Value™ of BDT50.92 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. JMI Hospital Requisite Manufacturing's Research & Development for the three months ended in Mar. 2026 was BDT0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was BDT0 Mil.

JMI Hospital Requisite Manufacturing  (DHA:JHRML) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JMI Hospital Requisite Manufacturing Research & Development Related Terms

JMI Hospital Requisite Manufacturing Research & Development Historical Data

* Premium members only.

The historical data trend for JMI Hospital Requisite Manufacturing's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Hospital Requisite Manufacturing Research & Development Chart

JMI Hospital Requisite Manufacturing Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
0.00 0.00 0.00 0.00 0.00

JMI Hospital Requisite Manufacturing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DHA:JHRML
67GF Score
JMI Hospital Requisite Manufacturing Ltd DHA:JHRML
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Hospital Requisite Manufacturing Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT0 Mil mean?
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a Research & Development of BDT0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on JMI Hospital Requisite Manufacturing and its competitors.
Is JMI Hospital Requisite Manufacturing's Research & Development too high?
JMI Hospital Requisite Manufacturing's current Research & Development is BDT0 Mil. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's Research & Development compare to ISRG and BDX?
JMI Hospital Requisite Manufacturing's Research & Development of BDT0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on JMI Hospital Requisite Manufacturing and its competitors. JMI Hospital Requisite Manufacturing's current Research & Development is BDT0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Fairly Valued. The stock's GF Value™ is BDT50.92, compared to a current price of BDT52.60 — trading 3.3% above its estimated fair value. The current Research & Development is BDT0 Mil. JMI Hospital Requisite Manufacturing's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current Research & Development is BDT0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?

Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be overvalued. The current stock price of BDT52.60 is trading 3.3% above its estimated GF Value™ of BDT50.92. GuruFocus considers JMI Hospital Requisite Manufacturing to be Fairly Valued.

Key valuation signals for DHA:JHRML:

  • Research & Development: BDT0 Mil
  • GF Value™: BDT50.92 vs. price of BDT52.60 (3.3% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JMI Hospital Requisite Manufacturing Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Hospital Requisite Manufacturing Ltd is engaged in the production of medical devices and components. The company produces health & hospicare products. The products of the company include Surgical Sutures, Surgical Gloves, IV Cannula, Bulk Needles, Blister Film, Infusion Set Components, Disposable Scalpels, Nasal Oxygen Cannulas, Blood Transfusion Sets, Urine Drainage Bags, Scalp Vein Sets, and others.
67GF Score

Get the complete analysis for DHA:JHRML

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT52.60
Price
BDT50.92
GF Value